英文名称 |
中文名称 |
CAS号 |
操作 |
Alectinib Hydrochloride |
艾乐替尼盐酸盐 |
1256589-74-8 |
详细
|
AZD1208 |
AZD1208 |
1204144-28-4 |
详细
|
Ombitasvir |
奥比他韦 |
1258226-87-7 |
详细
|
Tegatrabetan |
1227637-23-1 |
1227637-23-1 |
详细
|
EGFR-IN-7 (compound 34) |
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 |
2267329-76-8 |
详细
|
THPP-1 |
THPP-1 |
1257051-63-0 |
详细
|
DT2216 |
DT2216 |
2365172-42-3 |
详细
|
GDC-0879 |
2,3-二氢-5-[1-(2-羟基乙基)-3-(4-吡啶基)-1H-吡唑-4-基]-1H-茚-1-酮肟 |
905281-76-7 |
详细
|
DWK-1339 |
DWK-1339 |
1018946-38-7 |
详细
|
AP26113 |
AP26113 |
1197958-12-5 |
详细
|
Omaveloxolone (RTA-408) |
NRF1-ACTIVATOR-1 |
1474034-05-3 |
详细
|
Solcitinib |
SOLCITINIB |
1206163-45-2 |
详细
|
ESI-09 |
ESI-09 |
263707-16-0 |
详细
|
PRT 060318 |
PRT-060318 |
1194961-19-7 |
详细
|
Avapritinib (BLU-285) |
阿伐普替尼 |
1703793-34-3 |
详细
|
LMP744 |
308246-52-8 |
308246-52-8 |
详细
|
Imaradenant (AZD4635) |
AZD4635 |
1321514-06-0 |
详细
|
AMPA/kainate antagonist-2 |
(+)-5-(4-AMINO-3-METHYLPHENYL)-7-(2-THIAZOLYL)-8,9-DIHYDRO-7H-1,3-DIOXOLO-[4,5-H][2,3]BENZODIAZEPINE |
923271-87-8 |
详细
|
Topotecan |
拓扑替康 |
123948-87-8 |
详细
|
Vipivotide tetraxetan (PSMA-617) |
1702967-37-0 |
1702967-37-0 |
详细
|
Fantofarone |
泛托法隆 |
114432-13-2 |
详细
|
Poziotinib |
波齐替尼 |
1092364-38-9 |
详细
|
ACY-775 |
CS-2821 |
1375466-18-4 |
详细
|
MRT68921 HCl |
MRT68921 |
1190379-70-4 |
详细
|
Avitinib (AC0010) |
艾维替尼 |
1557267-42-1 |
详细
|
GSK180736A (GSK180736) |
CS-2541 |
817194-38-0 |
详细
|
BI-3802 |
顺式-2-((6-((5-氯-2-(3,5-二甲基哌嗪-1-基)嘧啶-4-基)氨基)-1-甲基-2-氧代-1,2-二氢喹啉-3-基)氧基)-N-甲基乙酰胺 |
2166387-65-9 |
详细
|
NIK SMI1 |
NIK SMI1 |
1660114-31-7 |
详细
|
5-(5-((1S,2R)-2-isopropylcyclopropyl)-6-methylpyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione |
5-[6-甲基-5-[(1S,2R)-2-丙-2-基环丙基]哒嗪-3-基]-1H-嘧啶-2,4-二酮 |
2375815-63-5 |
详细
|
Granisetron |
格拉司琼 |
109889-09-0 |
详细
|
AZ3976 |
化合物 T23764 |
1418747-15-5 |
详细
|
Doramapimod |
1-[2-(4-甲基苯基)-5-叔丁基吡唑-3-基]-3-[4-(2-吗啉-4-基乙氧基)萘-1-基]脲 |
285983-48-4 |
详细
|
Dovitinib (TKI258) Lactate |
多韦替尼 |
915769-50-5 |
详细
|
Unii-na83F1sjsr |
匹莫范色林 L-酒石酸盐 |
706782-28-7 |
详细
|
Daclatasvir Dihydrochloride |
达卡他韦二盐酸盐 |
1009119-65-6 |
详细
|
Cobimetinib |
考比替尼 |
934660-93-2 |
详细
|
N-[2-[6-[[(3,4-Dichlorophenyl)Methyl]aMino]-2-(4-Methoxyphenyl)-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl]ethyl]-acetaMide |
N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氢吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺 |
1018674-83-3 |
详细
|
Peficitinib |
培菲替尼 |
944118-01-8 |
详细
|
Elimusertib |
BAY-1895344 |
1876467-74-1 |
详细
|
SR59230A |
1-(2-ETHYLPHENOXY)-3-[[(1S)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENYL]AMINO]-(2S)-2-PROPANOL HYDROCHLORIDE |
174689-39-5 |
详细
|
ETC-206 (AUM 001) |
4-[6-[4-(4-吗啉基羰基)苯基]咪唑并[1,2-A]吡啶-3-基]苄腈 |
1464151-33-4 |
详细
|
TTK21 |
TTK21 |
709676-56-2 |
详细
|
JHU-083 |
化合物 T15613 |
1998725-11-3 |
详细
|
BRD4 Inhibitor-10 |
BRD4 INHIBITOR-10 |
1660117-38-3 |
详细
|
Pyridone6 |
2-(1,1-二甲基乙基)-9-氟-1,6-二氢-7H-苯并[H]咪唑并[4,5-F]异喹啉-7-酮 |
457081-03-7 |
详细
|
NVP-TNKS656 |
NVP-TNKS656 |
1419949-20-4 |
详细
|
HO-3867 |
HO-3867 |
1172133-28-6 |
详细
|
Ozanimod (RPC1063) |
奥扎莫德 |
1306760-87-1 |
详细
|
MIK665 |
S64315(MIK665) |
1799631-75-6 |
详细
|
CID 1375606 |
CID-1375606 |
313493-80-0 |
详细
|
DLinDMA |
871258-12-7 |
871258-12-7 |
详细
|
MPP+ iodide |
1-甲基-4-苯基吡啶鎓碘化物 |
36913-39-0 |
详细
|
CC-92480 |
CC-92480 |
2259648-80-9 |
详细
|
GSK962 |
1-Propanone, 1-[(5R)-4,5-dihydro-5-phenyl-1H-pyrazol-1-yl]-2,2-dimethyl- |
2049872-86-6 |
详细
|
TCS PIM-1 1 |
TCS PIM-1 1 |
491871-58-0 |
详细
|
Filgotinib (GLPG0634) |
非戈替尼 |
1206161-97-8 |
详细
|
AZD3759 |
AZD3759 |
1626387-80-1 |
详细
|
PLX7904 |
PLX7904 |
1393465-84-3 |
详细
|
YKL06-061 |
YKL 06-061 |
2172617-15-9 |
详细
|
BI-3812 |
CPD1815 |
2166387-64-8 |
详细
|
ML198 |
化合物ML198 |
1380716-06-2 |
详细
|
LYS006hcl |
(ΒS)-Β-氨基-5-[4-[(5-氯-3-氟-2-吡啶基)氧基]苯基]-2H-四唑-2-丁酸 |
1799681-85-8 |
详细
|
NVP-BSK805 |
NVP-BSK805 dihydrochloride |
1092499-93-8 |
详细
|
2-(2-Chlorophenyl)-4-(3-(diMethylaMino)phenyl)-5-Methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione |
2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮 |
1218942-37-0 |
详细
|
SMCC-DM1 |
DM1-SMCC |
1228105-51-8 |
详细
|
RAF709 |
化合物RAF709 |
1628838-42-5 |
详细
|
BMS-986158 |
1800340-40-2 |
1800340-40-2 |
详细
|
Verteporfin |
维替泊芬 |
129497-78-5 |
详细
|
Z433927330 |
Z433927330 |
1005883-72-6 |
详细
|
1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(4-cyanophenoxy)phenyl)urea |
SC-1 |
1313019-65-6 |
详细
|
Dabrafenib mesylate |
达帕菲尼甲磺酸盐 |
1195768-06-9 |
详细
|
Ceritinib dihydrochloride |
双盐酸盐色瑞替尼 |
1380575-43-8 |
详细
|
Sacubitril/Valsartan |
LCZ696 |
936623-90-4 |
详细
|
Nk-252 |
1414963-82-8 |
1414963-82-8 |
详细
|
PH-002 |
1311174-68-1 |
1311174-68-1 |
详细
|
FIT-039 |
FIT-039 |
1113044-49-7 |
详细
|
AZ9482 |
AZ 9482;AZ-9482 |
1825345-33-2 |
详细
|
Mobocertinib |
莫博替尼 |
1847461-43-1 |
详细
|
TYK2-IN-4 |
BMS-986165 |
1609392-27-9 |
详细
|
P110δ-IN-1,ME401 |
ME401 |
1595129-71-7 |
详细
|
Selumetinib (AZD6244) |
司美替尼 |
606143-52-6 |
详细
|
BAY 61-3606 dihydrochloride |
BAY 61-3606 |
648903-57-5 |
详细
|
Pacritinib |
帕克替尼 |
937272-79-2 |
详细
|
Lorediplon |
LOREDIPLON |
917393-39-6 |
详细
|
BX430 |
BX 430 |
688309-70-8 |
详细
|
Nedisertib (M3814) |
NEDISERTIB |
1637542-33-6 |
详细
|
5-(4-PHENOXYBUTOXY)PSORALEN |
4-(4-苯氧基丁氧基)-7H-呋喃并[3,2-G][1]苯并吡喃-7-酮 |
870653-45-5 |
详细
|
Lazertinib |
YH-25448 |
1903008-80-9 |
详细
|
Dynarrestin |
Dynarrestin |
2222768-84-3 |
详细
|
AZD7648 |
AZD-7648 |
2230820-11-6 |
详细
|
GN44028 |
GN44028 |
1421448-26-1 |
详细
|
Pimasertib (AS-703026) |
N-[(2S)-2,3-二羟基丙基]-3-[(2-氟-4-碘苯基)氨基]-4-吡啶甲酰胺 |
1236699-92-5 |
详细
|
AZD-7325 |
3-CinnolinecarboxaMide, 4-aMino-8-(2-fluoro-6-Methoxyphenyl)-N-propyl- |
942437-37-8 |
详细
|
Indotecan |
Indotecan |
915303-09-2 |
详细
|
Nilotinib hydrochloride |
尼罗替尼盐酸盐(无水) |
923288-95-3 |
详细
|
EED226 |
EED226 |
2083627-02-3 |
详细
|
NSC45586 |
Benzoic acid,5-[2-[4-[2-(2,4-diamino-5-methylphenyl)diazenyl]phenyl]diazenyl]-2-hydroxy-,sodium salt (1:1) |
6300-44-3 |
详细
|
ADX-102 |
REPROXALAP |
916056-79-6 |
详细
|
Naltrexone |
纳曲酮 |
16590-41-3 |
详细
|
H 89 2HCl |
H-89二盐酸盐 |
130964-39-5 |
详细
|